Mechanism studies have indicated that FoxM1 can promote glioma progression by enhancing MMP2 transcription19 or temozolomide (TMZ) resistance by up‐regulating RFC5 expression directly.20 The gene discussed is MMP2; the disease is central nervous system cancer.